- SPACs
- Ithaka Acquisition Corp
Ithaka Acquisition Corp
Completed 2007-06-21- CIK 1324205
- ITHK
- IPO 2005-08-18
- $46.9M trust
- 213 filings
Successfully merged with Alsius Corporation
- IPO Size
- $53.1M
- raised at the IPO
- Trust Amount
- $46.9M
- held for shareholders
- Current Status
- Completed
- from its latest filing
- IPO Year
- 2005
- year it listed
Filings, by quarter
213 filings over 17 quarters; violet bars carry a milestone
- 05 Q2: 3 filings
- 05 Q3: 22 filings
- 05 Q4: 2 filings
- 06 Q1: 7 filings
- 06 Q2: 1 filing
- 06 Q3: 2 filings
- 06 Q4: 9 filings
- 07 Q1: 13 filings
- 07 Q2: 56 filings
- 07 Q3: 26 filings
- 07 Q4: 11 filings
- 08 Q1: 22 filings
- 08 Q2: 6 filings
- 08 Q3: 6 filings
- 08 Q4: 2 filings
- 09 Q1: 17 filings
- 09 Q2: 8 filings
- S-1 filed 05 Q2
- IPO 05 Q3
- Definitive agreement 06 Q4
- Completed 07 Q2
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
- Registration2005-05-02 Filed S1
- IPO2005-08-18 IPO, search begins
- Definitive Agreement2006-10-03 Agreement for merger
- Completed2007-06-21 Merger Completed
About
Ithaka Acquisition Corp. is a blank-check company formed to acquire an operating business in the healthcare industry, with its search concentrated on specified healthcare segments.
Investment Focus
Healthcare, Biopharmaceuticals
Geographic Focus
United States
Key Information
As the filings state it
- IPO Date
- 2005-08-18
- Jurisdiction of Incorporation
- Delaware
- SIC
- 6770
- Completion Date
- 2007-06-21
- Merger Target
- Alsius Corporation
- SPAC Ticker
- ITHK
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
The team comprises Paul A. Brooke, Eric Hecht, and John M. Glazer, whose backgrounds include healthcare research and investment banking, venture capital, and pharmaceutical and biotechnology work.